Cargando…
Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034568/ https://www.ncbi.nlm.nih.gov/pubmed/35901280 http://dx.doi.org/10.1182/bloodadvances.2021006845 |
_version_ | 1784911243498225664 |
---|---|
author | Shi, Hui Zheng, Peihao Liu, Rui Xu, Teng Yang, Fan Feng, Shaomei Guo, Yuelu Ma, Lixia Liu, Haidi Lei, Yang Li, Ruiting Deng, Biping Hou, Shuling Li, Yang Zheng, Qinlong Hu, Kai Ke, Xiaoyan |
author_facet | Shi, Hui Zheng, Peihao Liu, Rui Xu, Teng Yang, Fan Feng, Shaomei Guo, Yuelu Ma, Lixia Liu, Haidi Lei, Yang Li, Ruiting Deng, Biping Hou, Shuling Li, Yang Zheng, Qinlong Hu, Kai Ke, Xiaoyan |
author_sort | Shi, Hui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10034568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-100345682023-03-24 Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL Shi, Hui Zheng, Peihao Liu, Rui Xu, Teng Yang, Fan Feng, Shaomei Guo, Yuelu Ma, Lixia Liu, Haidi Lei, Yang Li, Ruiting Deng, Biping Hou, Shuling Li, Yang Zheng, Qinlong Hu, Kai Ke, Xiaoyan Blood Adv Research Letter The American Society of Hematology 2022-07-30 /pmc/articles/PMC10034568/ /pubmed/35901280 http://dx.doi.org/10.1182/bloodadvances.2021006845 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Letter Shi, Hui Zheng, Peihao Liu, Rui Xu, Teng Yang, Fan Feng, Shaomei Guo, Yuelu Ma, Lixia Liu, Haidi Lei, Yang Li, Ruiting Deng, Biping Hou, Shuling Li, Yang Zheng, Qinlong Hu, Kai Ke, Xiaoyan Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL |
title | Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL |
title_full | Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL |
title_fullStr | Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL |
title_full_unstemmed | Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL |
title_short | Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL |
title_sort | genetic landscapes and curative effect of car t-cell immunotherapy in patients with relapsed or refractory dlbcl |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034568/ https://www.ncbi.nlm.nih.gov/pubmed/35901280 http://dx.doi.org/10.1182/bloodadvances.2021006845 |
work_keys_str_mv | AT shihui geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT zhengpeihao geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT liurui geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT xuteng geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT yangfan geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT fengshaomei geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT guoyuelu geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT malixia geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT liuhaidi geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT leiyang geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT liruiting geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT dengbiping geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT houshuling geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT liyang geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT zhengqinlong geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT hukai geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl AT kexiaoyan geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl |